Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Caris Life Sciences Stories

2013-10-09 08:27:22

Key components include an upgraded online physician portal, simplified genomic profile and newly-added biomarkers to support more informed therapeutic selections IRVING, Texas, Oct. 9, 2013 /PRNewswire/ -- Caris Life SciencesĀ®, a leading biosciences company focused on fulfilling the promise of personalized medicine, today launched significant enhancements to its Molecular Intelligence(TM) tumor profiling service. These enhancements include significant updates to MI Portal(TM), the...

2013-09-29 00:21:19

Embargo: 6:01 pm ET, Sunday, September 29, 2013 AMSTERDAM, Sept. 29, 2013 /PRNewswire/ -- Caris Life Sciences announced today data from two studies presented at the 2013 European Cancer Congress (ECC 2013), which demonstrate the potential of evidence-guided molecular profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) origins as well as rare tumors and cancers that have been refractory to treatment....

2013-08-22 08:26:42

Expansion offers key international markets innovative, thorough biomarker analysis to improve care for cancer patients IRVING, Texas, Aug. 22, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence(TM), in select Middle Eastern and African markets. Given...

2013-06-02 08:20:14

Analysis of world's largest commercial cancer patient database uncovers clinically actionable targets IRVING, Texas, June 2, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, will present findings today at the 2013 ASCO annual meeting from the analysis of its Caris Molecular Intelligence(TM) database. This database examined the results of molecular profiling of both common and rare cancer types for...

2013-05-31 08:24:11

Supplementary Genomic Analysis Will Offer Complement to Best-in-Class Molecular Profiling Clinical Tool IRVING, Texas, May 31, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced it intends to expand its Next-Generation Sequencing (NGS) capabilities to include whole exome and transcriptome sequencing. The offering will provide physicians with an in-depth report focusing on the 452...

2013-05-29 08:30:28

Evidence-Guided Molecular Profiling Services will be featured in three separate data presentations IRVING, Texas, May 29, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced that three data presentations on Caris Molecular Intelligence(TM), the world's foremost, evidence-guided molecular profiling service, will take place this weekend at the 2013 annual meeting of the American Society...

2013-04-16 12:27:38

Five Separate Research Presentations Offer Data on the Possible Future Application of Circulating Microvesicles to Cancer Care IRVING, Texas, April 16, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, today announced that five data presentations related to blood-based circulating microvesicles (cMVs) will be presented this week at the 2013 International Society for Extracellular Vesicles (ISEV)...

2013-03-08 08:22:35

March 10 Event at SGO Annual Meeting to Feature Presentations by Noted Experts in Gynecologic Oncology and Molecular Genetics IRVING, Texas, March 8, 2013 /PRNewswire/ -- Caris Life Sciences(TM), a leading biosciences company focused on fulfilling the promise of personalized medicine, will sponsor an expert symposium, Integrating Next Generation Sequencing Into the Clinical Management of Gynecologic Cancers, at the 2013 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's...

2013-03-05 08:30:41

Role will help further advance revolutionary blood-based technology IRVING, Texas, March 5, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, announced today that it has named Joachim Schorr, PhD, as its Chief Scientific Officer. He joins Caris in this role after working as a consultant with the company during the past year. In this expanded capacity, Dr. Schorr's extensive expertise in the...

2013-01-28 08:29:41

IRVING, Texas, Jan. 28, 2013 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, announced today the commercial availability of mutational analysis by Next-Generation Sequencing (NGS), which will replace its former mutational analysis platform. NGS joins an extensive collection of tumor profiling technologies currently employed by Caris Molecular Intelligence(TM) Service (MI Profile(TM)), including...